JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 10 953-960
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McElvany, K. D.
Right arrow Articles by Welch, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McElvany, K. D.
Right arrow Articles by Welch, M. J.

Characterization of Bromine-77-Labeled Proteins Prepared Using Bromoperoxidase

Karen D. McElvany and Michael J. Welch

The Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Correspondence: For reprints contact: Michael J. Welch, PhD, Div. of Radiation Sciences, Edward Mallinckrodt Institute of Radiology, 510 S. Kingshighway, St. Louis, MO 63110.

ABSTRACT

The halogenating enzyme bromoperoxidase, isolated from the red algae Bonnemaisonia hamifera and Penicillus capitatus, was used to catalyze the radiohalogenation of proteins at neutral pH. Human serum albumin and canine fibrinogen were halogenated as model compounds; the proteins were labeled with Br-77, produced by the 75As({alpha},2n)77Br reaction. For each enzyme, the essential reaction parameters (including the concentrations of hydrogen peroxide or of protein, the amount of enzyme used to catalyze the reaction, the pH of the reaction mixture, and the reaction time) were varied to obtain conditions that resulted in the highest yield of radiolabeled protein.

The labeled proteins prepared with bromoperoxidase are stable with respect to loss of the radiolabel by hydrolysis and retain their biologic activity. The extension of this method to radiobromination of other types of compounds for imaging and receptor studies seems promising. Also, proteins and other compounds may be labeled with shorter-lived, positron-emitting isotopes of bromine for use in conjunction with computer-assisted positron tomography.




This article has been cited by other articles:


Home page
JNMHome page
R. Rossin, D. Berndorff, M. Friebe, L. M. Dinkelborg, and M. J. Welch
Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin
J. Nucl. Med., July 1, 2007; 48(7): 1172 - 1179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Thomas, P. M. Bozeman, M. M. Jefferson, and C. C. King
Oxidation of Bromide by the Human Leukocyte Enzymes Myeloperoxidase and Eosinophil Peroxidase
J. Biol. Chem., February 17, 1995; 270(7): 2906 - 2913.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S. Weiss, S. Test, C. Eckmann, D Roos, and S Regiani
Brominating oxidants generated by human eosinophils
Science, October 10, 1986; 234(4773): 200 - 203.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.